Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma

Eur Radiol. 2017 Jun;27(6):2563-2569. doi: 10.1007/s00330-016-4621-y. Epub 2016 Oct 17.

Abstract

Objectives: To determine whether washout characteristics of dynamic contrast-enhanced computed tomography (CT) could predict survival in patients with extrahepatic cholangiocarcinoma (EHC).

Methods: This study collected 46 resected cases. All cases were examined by dynamic contrast study on multidetector-row CT. Region-of-interest measurements were obtained at the non-enhanced, portal venous phase and delayed phase in the tumour and were used to calculate the washout ratio as follows: [(attenuation value at portal venous phase CT - attenuation value at delayed enhanced CT)/(attenuation value at portal venous phase CT - attenuation value at unenhanced CT)] × 100. On the basis of the median washout ratio, we classified the cases into two groups, a high-washout group and low-washout group. Associations between overall survival and various factors including washout rates were analysed.

Results: The median washout ratio was 29.4 %. Univariate analysis revealed that a lower washout ratio, venous invasion, lymphatic permeation and lymph node metastasis were associated with shorter survival. Multivariate analysis identified the lower washout ratio as an independent prognostic factor (hazard ratio, 3.768; p value, 0.027).

Conclusions: The washout ratio obtained from the contrast-enhanced CT may be a useful imaging biomarker for the prediction of survival of patients with EHC.

Key points: • Dynamic contrast study can evaluate the aggressiveness of extrahepatic cholangiocarcinoma. • A lower washout ratio was an independent prognostic factor for overall survival. • CT can predict survival and inform decisions on surgical options or chemotherapy.

Keywords: Contrast enhancement pattern; Extrahepatic cholangiocarcinoma; Multidetector computed tomography; Pathology; Prognosis.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms / diagnostic imaging*
  • Bile Duct Neoplasms / mortality
  • Bile Duct Neoplasms / surgery
  • Cholangiocarcinoma / diagnostic imaging*
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / surgery
  • Contrast Media
  • Female
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multidetector Computed Tomography / methods
  • Multidetector Computed Tomography / mortality
  • Multimodal Imaging / methods
  • Multimodal Imaging / mortality
  • Portal Vein / diagnostic imaging
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Tomography, Spiral Computed / methods
  • Tomography, Spiral Computed / mortality

Substances

  • Contrast Media